Why Axis-Shield's path to growth is paved with serendipity
This article was originally published in Clinica
David Evans is proof that there can be life after merger. The former CEO of Shield Diagnostics spent some time as co-managing director with Svein Lien from the Norwegian side of the business, who is now group CEO, before stepping down to the deputy CEO role, with special responsibility for the laboratory division.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.